The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

NCT02494349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

LUTS(Lower Urinary Tract Symptoms)
Benign Prostatic Hyperplasia
Overactive Bladder

Interventions

DRUG: JLP-1207
DRUG: Solifenacin 5mg+Tamsulosin 0.2mg

Sponsor

Jeil Pharmaceutical Co., Ltd.